Abstract:Introduction: High-altitude polycythemia (HAPC) is a common chronic high-altitude disease characterized by significantly increased erythrocyte, hemoglobin (Hb), and hematocrit values and decreased arterial oxygen saturation. The mechanisms underlying HAPC development are unclear; we aimed to investigate this in an HAPC rat model. Methods: Twelve Sprague–Dawley rats were divided into control and HAPC groups. The HAPC group was exposed to hypobaric hypoxia. This HAPC model was assessed using routine blood tests and blood gas analyses. Bone marrow, peripheral blood reticulocytes (RETs), and peripheral blood erythrocyte apoptosis were measured using flow cytometry. Erythrocyte osmotic fragility (EOF) tests were conducted. Abnormal erythrocytes were counted using electron microscopy. Plasma-free hemoglobin, 5′-nucleotidase (CD73), adenosine, erythrocyte cytosolic adenosine, sphingosine-1-phosphate (S1P), and 2,3-bisphosphoglycerate (BPG) levels were measured using enzyme-linked immunosorbent assays. Erythrocyte metabolic pathway-related protein [adenosine A2B receptor (ADORA2B), erythrocyte equilibrative nucleoside transporter 1 (eENT1), sphingosine kinase 1 (SPHK1), phospho-SPHK1, bisphosphoglycerate mutase (BPGM), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)] levels were assessed by Western blotting. Results: The HAPC rat model was successfully established (Hb > 210 g/L). Indices of bone marrow and peripheral blood RET proportions were significantly higher in the HAPC than the control group ( p = 0.04 and p < 0.001, respectively). The proportion of peripheral blood erythrocytes in early apoptosis was significantly lower in the HAPC than the control group ( p < 0.001). Vesicular erythrocyte and acanthocyte proportions were significantly higher in the HAPC than the control group ( p < 0.001 and p = 0.019, respectively). The EOF tests revealed that 50% erythrocyte hemolysis occurred at 4.0–4.5 and 4.5–5.0 g/L NaCl in the control and HAPC groups, respectively. Plasma-free hemoglobin, CD73, adenosine, erythrocyte cytosolic adenosine, S1P, and 2,3-BPG levels and ADORA2B, eENT1, phospho-SPHK1, S1P, BPGM, and GAPDH erythrocyte expression levels (all p ≤ 0.02) were significantly higher in the HAPC than the control group. Conclusion: In model rats, an HAPC-related erythrocyte increase was associated with enhanced bone marrow hematopoietic function and reduced erythrocyte apoptosis, whereas numerous abnormal erythrocytes, increased EOF, and reduced hemolysis resistance were associated with erythrocyte metabolism. CD73/adenosine/S1P/2,3-BPG and eENT1/adenosine/BPGM/2,3-BPG metabolic pathways in erythrocytes were activated in HAPC rats, facilitating oxygen release. These findings further reveal the intrinsic HAPC mechanism and forms a basis for future development of preventive and therapeutic strategies for HAPC.

Elevated Pentose Phosphate Pathway is Involved in the Recovery of Hypoxia-Induced Erythrocytosis

Alteration in the number, morphology, function, and metabolism of erythrocytes in high-altitude polycythemia

Erythrocytes Display Metabolic Changes in High-Altitude Polycythemia.

High-altitude hypoxia exposure inhibits erythrophagocytosis by inducing macrophage ferroptosis in the spleen

Ameliorating effects of the HIF-2α inhibitor PT2385 on high-altitude polycythemia

Changes in Expression Levels of Erythrocyte and Immune-Related Genes Are Associated with High Altitude Polycythemia.

Therapeutic Erythrocytapheresis Is Effective in Treating High Altitude Polycythemia on the Qinghai-Tibet Plateau

[Progress in multiomics research on high altitude polycythemia]

Plasma exosomal microRNA expression profiles in patients with high-altitude polycythemia

Deciphering the Efficacy and Mechanism of Astragalus membranaceus on High Altitude Polycythemia by Integrating Network Pharmacology and In Vivo Experiments

Serum Inflammatory Factor Profiles in the Pathogenesis of High-Altitude Polycythemia and Mechanisms of Acclimation to High Altitudes

Tyrosine phosphorylation of band 3 impairs the storage quality of suspended red blood cells in the Tibetan high-altitude polycythemia population

Deciphering the Efficacy and Mechanism of <i>Astragalus membranaceus</i> on High Altitude Polycythemia by Integrating Network Pharmacology and In Vivo Experiments

Effect of Therapeutic Erythrocytapheresis on Outcomes and Renal Benefit in Patients with High-Altitude Polycythemia: a Real-World Study

GATA-1 Promotes Erythroid Differentiation Through the Upregulation of <i>miR-451a</i> and <i>miR-210-3p</i> Expressions in CD34<SUP>+</SUP> Cells in High-Altitude Polycythemia

[Effect of PD98059 on Proliferation and Apoptosis of CD71(+),CD235a(+) Nucleated Erythrocytes in the Patients with High Altitude Polycythemia].

Transcriptomic Profiling Reveals Gene Expression Kinetics in Patients with Hypoxia and High Altitude Pulmonary Edema.

High altitude polycythemia and its maladaptive mechanisms: an updated review

Clinicopathological characteristics of high-altitude polycythemia-related kidney disease in Tibetan inhabitants

Influence of HIF-2α on the Expression of GATA-1 in Bone Marrow CD71 + Cell of High Altitude Polycythemia Rat Model

Alterations of Human Plasma Proteome Profile on Adaptation to High-Altitude Hypobaric Hypoxia